Duncraig, Australia

Yan Chen

This inventor holds 1 USPTO granted patent. Top assignee: Paragon Medical, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Chen. Retrieved from https://idiyas.com/inventor/yan-chen-4gvxclyj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yan Chen - Innovator in Controlled Release Drug Preparations

Introduction

Yan Chen is a notable inventor based in Duncraig, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release preparations for cytotoxic or cytostatic drugs. Her innovative work has the potential to enhance the efficacy and safety of cancer treatments.

Latest Patents

Yan Chen holds 1 patent for her invention related to controlled release preparations. This patent addresses the challenges associated with delivering cytotoxic and cytostatic drugs effectively, ensuring that patients receive optimal therapeutic benefits while minimizing side effects.

Career Highlights

Yan is currently employed at Paragon Medical, Inc., where she continues to advance her research and development efforts. Her work at the company focuses on improving drug delivery systems, which is crucial for enhancing patient outcomes in medical treatments.

Collaborations

Yan collaborates with her coworker, Bruce Nathaniel Gray, to further explore innovative solutions in the pharmaceutical industry. Their combined expertise contributes to the development of cutting-edge technologies that aim to improve drug efficacy and patient care.

Conclusion

Yan Chen's contributions to the field of controlled release drug preparations exemplify her commitment to innovation in medicine. Her work not only advances scientific knowledge but also has the potential to significantly impact patient treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…